Mesoblast Limited (MESO) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MESO Revenue Growth
Revenue Breakdown
MESO's revenue distribution by segment and geography
By Geography
MESO Revenue Analysis (2014–2025)
As of May 8, 2026, Mesoblast Limited (MESO) generated trailing twelve-month (TTM) revenue of $17.2 million, reflecting explosive growth of +458.6% year-over-year. The most recent quarter (Q4 2025) recorded $7.0 million in revenue, up 0.0% sequentially.
Looking at the longer-term picture, MESO's 5-year compound annual growth rate (CAGR) stands at -11.8%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $42.5 million in 2016.
When compared to Healthcare sector peers including FATE (-51.2% YoY), MDXG (+10.5% YoY), and ANIK (+23.2% YoY), MESO has outperformed the peer group in terms of revenue growth. Compare MESO vs FATE →
MESO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MESOCurrent | $17M | +458.6% | -11.8% | -363.1% | |
 FATE | $7M | -51.2% | -26.7% | -2222.4% | |
 MDXG | $419M | +10.5% | +11.0% | 15.3% | |
 ANIK | $113M | +23.2% | -2.9% | -9.8% | |
 RGEN | $738M | +17.4% | +15.0% | 8.1% | |
 CYTK | $88M | +450.6% | +9.5% | -695.4% |
MESO Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $17.2M | +191.4% | $12.1M | 70.2% | $-62,443,000 | -363.1% |
| 2024 | $5.9M | -21.3% | $-35,168,000 | -595.9% | $-84,147,000 | -1425.7% |
| 2023 | $7.5M | -26.5% | $-47,421,000 | -632.2% | $-69,289,000 | -923.7% |
| 2022 | $10.2M | +37.0% | $-53,361,000 | -522.6% | $-80,574,000 | -789.1% |
| 2021 | $7.5M | -76.8% | $-78,275,000 | -1049.8% | $-109,096,000 | -1463.2% |
| 2020 | $32.2M | +92.3% | $-49,341,000 | -153.4% | $-74,872,000 | -232.8% |
| 2019 | $16.7M | -3.6% | $-58,451,000 | -349.5% | $-80,202,000 | -479.6% |
| 2018 | $17.3M | +618.9% | $11.8M | 68.2% | $-77,339,000 | -446.0% |
| 2017 | $2.4M | -94.3% | $-9,653,000 | -400.2% | $-90,042,000 | -3733.1% |
| 2016 | $42.5M | +79.2% | $12.8M | 30.0% | $-55,888,000 | -131.4% |
See MESO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MESO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MESO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMESO — Frequently Asked Questions
Quick answers to the most common questions about buying MESO stock.
Is MESO's revenue growth accelerating or slowing?
MESO revenue is accelerating at +458.6% year-over-year, exceeding the 5-year CAGR of -11.8%. TTM revenue reached $17M. Growth momentum has increased versus prior periods.
What is MESO's long-term revenue growth rate?
Mesoblast Limited's 5-year revenue CAGR of -11.8% reflects the sustained expansion pattern. Current YoY growth of +458.6% is above this long-term average.
How is MESO's revenue distributed by segment?
MESO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.